Purpose Neuronal system activity plays an important role for the prognosis of patients with atrial fibrillation (AF). Using 123 I metaiodobenzylguanidine ( 123 I-MIBG) scintigraphy, we investigated whether a cardiac sympathetic nervous system (SNS) abnormality would be associated with an increased risk of vascular events in patients with paroxysmal AF. Methods 123 I-MIBG scintigraphy was performed in 69 consecutive patients (67±13 years, 62% men) with paroxysmal AF who did not have structural heart disease. SNS integrity was assessed from the heart to mediastinum (H/M) ratio on delayed imaging. Serum concentration of Creactive protein (CRP) was measured before 123 I-MIBG study.
Introduction
Atrial fibrillation (AF) is associated with an increased risk of cardiac events, stroke and all-cause mortality [1, 2] . Structural heart disease is a specific cardiovascular condition associated with AF [1] , and left ventricular dysfunction caused by heart diseases or sustained AF itself increases the risk of heart failure or ischaemic stroke [3, 4] . The thromboembolic event rate is lower in patients with AF who did not have structural heart disease, heart failure or left ventricular dysfunction [1] . However, approximately 5% of patients per year develop concomitant features that put them at high risk for stroke, and these patients with idiopathic AF who subsequently have a cerebral event develop more than one risk factor for stroke before the occurrence of life-threatening stroke [5] [6] [7] . Patients with paroxysmal AF were also considered to be at an earlier stage of the arrhythmia [8] , but recent studies showed that paroxysmal AF carries the same risk of thromboembolitic complications as permanent AF despite less structural remodelling of the atria compared to permanent AF [9, 10] .
Recently, cardiac sympathetic nervous system (SNS) abnormality has been shown to play an important role for the initiation and maintenance of AF [1] , morbidity and mortality [11] similar to inflammation [12] . We hypothesized that SNS abnormality would be associated with vascular events in patients with paroxysmal AF.
Materials and methods

Study population
We studied patients with suspected rhythm disorder from December 1995 to December 2008 at Showa University Hospital. The condition of arrhythmia was diagnosed on the basis of documented AF by ambulance monitoring, 12-lead electrocardiography or Holter monitoring. The diagnosis of AF was made when visible P waves on all 12 leads of the ECG were absent and an irregular random ventricular response was present [1] . AF was considered paroxysmal if the fibrillatory process ended spontaneously after some seconds, minutes, hours or up to 7 days. Permanent AF was defined as the ECG documentation of AF on two consecutive ECG separated by a minimum of 1 week and pharmacological therapy, direct current cardioversion and/ or catheter ablation had failed to recover the condition of sinus rhythm. Those patients with persistent (not selfterminating, but recovery of sinus rhythm by therapies) or permanent AF were excluded at the time of entry. Left ventricular ejection fraction (LVEF) and left atrial dimension (LAD) were measured by two-dimensional echocardiography before the study. Patients with left ventricular dysfunction (LVEF <50%), history of valvular disease including rheumatic causes, congenital heart disease, ischaemic heart disease and cardiomyopathy were excluded from this study. Patients were also excluded from this study if they had pre-excitation syndrome, atrioventricular tachycardia or ventricular tachyarrhythmia, atrial flutter or implanted pacemaker before the study. Patients who had autonomic nervous system abnormality such as hyperthyroidism, Parkinson disease or degenerative cerebral disease and patients who had a history of known thrombus or vascular events were also excluded from this study.
Complying with the Declaration of Helsinki, all patients gave written informed consent before this study, and the protocol was approved by our Institutional Review Board. Data collected prospectively included: demographics, existing medical diagnoses, symptoms, risk factors for vascular disease, medications, previous cardiac procedures and prior history of vascular event. Finally, 123 I metaiodobenzylguanidine ( 123 I-MIBG) scintigraphy was performed during stable sinus rhythm to assess SNS activity in 69 consecutive patients (mean ± standard deviation, age: 67±13 years, 62% men) with paroxysmal AF who did not have structural heart disease (idiopathic).
I-MIBG scintigraphy
From 1 day before to 1 day after the study, 1 mg of potassium iodine was given orally to block thyroid uptake of 123 I-MIBG. 123 I-MIBG scintigraphy was performed in the condition of sinus rhythm, without the presence of tachyarrhythmia. A total of 111 MBq of 123 I-MIBG was injected intravenously (Dai-ichi Radioisotope Laboratories, Chiba, Japan) and flushed with normal saline solution. Myocardial images were acquired using a standard-field gamma camera equipped with a medium-energy, parallelhole collimator (Prism 2000XP, Phillips, USA). A 20% window centred at 159 keV was used. Patients were placed in the supine position, and planar imaging was performed in the anterior view of the chest for 6 min. Identical acquisitions were obtained 15 min (early images) and 4 h (delayed images) after tracer injection. Images of 512×512 matrixes and 1.0 of zoom ratio were collected in an Odyssey computer (Prism 2000XP, Phillips, USA) for later analysis. Left ventricular MIBG activity was measured using a manually drawn region of interest around the left ventricular myocardium [13, 14] . A 20×20 pixel region of interest was placed over the upper mediastinal area. To evaluate the myocardial accumulation of MIBG, the heart to mediastinal (H/M) activity ratio was calculated from delayed images obtained at 4 h after injection of the tracer. Blood samples were obtained before injection of 123 I-MIBG to measure serum concentration of C-reactive protein (CRP). CRP was assayed by a latex immunonephelometric method with an assay range of 0.1-30 mg/dl using an automatic analyser (7350 Clinical Analyzer, Hitachi High-Tech Trading Co., Tokyo, Japan).
End-point
The mean follow-up time was 4.5±3.6 years (range for survivors: 0.2-12.9 years). The primary end-point of this study was the occurrence of cerebrovascular disease such as cerebral infarction or intracerebral haemorrhage (but not transient ischaemic attacks). Further, the primary end-point included a cardiovascular event such as myocardial infarction, or a clinical diagnosis of heart failure requiring hospitalization, and death caused by those follow-up events as previously defined [15] . These were confirmed by dedicated research personnel using a scripted review of the medical record or telephone interview.
Statistical analysis
For descriptive purposes, the patients were divided into two groups on the basis of the H/M ratio, CRP and LAD. Continuous variables are presented as means ± standard deviation. Differences between groups were tested using analysis of variance (ANOVA), the post hoc test or the chisquare test, as appropriate. Receiver-operating characteristic analysis was performed to define thresholds for the H/M ratio, CRP or LAD; this analysis provided optimal sensitivity and specificity in predicting the risk of cardiac/ cerebral events. Thresholds were obtained by minimizing the expression. The optimal thresholds for the prediction of follow-up events were at an H/M ratio=2.67 (sensitivity of 73.7% and specificity of 82%) ( Fig. 1 ), CRP=0.28 mg/dl (sensitivity of 57.9% and specificity of 80%) and LAD= 41.9 mm (sensitivity of 47% and specificity of 60%). An association between low H/M ratio (<2.7), high CRP (≥0.3 mg/dl) or LAD enlargement (≥42 mm) and followup events was formally tested by construction of KaplanMeier curves [16] and Cox proportional hazards model [17] . The statistical analysis was done using SPSS for Windows version 11 (SPSS Inc., Chicago, IL, USA).
Results
Follow-up events in patients with paroxysmal AF
During a mean of 4.5±3.6 years follow-up, 19 patients (27.5%) had events (stroke in nine patients, brain haemorrhage in one patient, myocardial infarction in two patients and heart failure in seven patients). Of seven patients with heart failure, five patients had a rapid ventricular rate of AF during heart failure and two patients had a rapid sinus rhythm rate. Four patients died of stroke and one patient died of pump failure. The events occurred from 0.2 years until 11.5 years (1.6 patients per year). The patients with occurrence of follow-up events were older than the patients without events (p<0.001), but there were no significant differences between the patients with and without occurrence of events regarding gender, cardiovascular or cerebrovascular risk factors and haemodynamic responses (Table 1) . Risk factors such as obesity or hypertension were controlled by diet, salt restriction and medication after entry into this study. All patients did not have a history of alcohol abuse, genetic factors and sleep apnea. Those were confirmed using a scripted review of the medical record or direct interview of the patient. The H/M ratio was lower (p=0.003) in patients with events compared to the patients without events, but LAD, LVEF and cardiothoracic ratio were similar between the patients with and without events.
The inflammatory markers such as number of white blood cells and CRP were higher in patients with events than those in patients without events (p<0.0001). Use of medication was not associated with the events. Use of antiarrhythmic drugs such as sodium channel blockers or sotalol was also not associated with the events. Amiodarone was not used at the time of entry in patients with paroxysmal AF. Transition to permanent AF from paroxysmal AF was associated with the occurrence of events (p=0.014) ( Table 1) .
Predictors of follow-up events in patients with paroxysmal AF SNS abnormality, defined as the H/M ratio <2.7, was a powerful predictor of the vascular events ( Fig. 2) (Table 2) . Older age (≥76 years old) was also a powerful predictor of the events, followed by high CRP (≥0.3 mg/dl) (Fig. 3) , but not LAD enlargement (≥42 mm). A combination of SNS abnormality and high CRP was a more powerful predictor of the events compared to the other markers (Fig. 4) . In multivariate analysis, after adjustment for potential confounding variables such as age, gender, transition to permanent AF and left ventricular function, SNS abnormality was an independent predictor of vascular events with a hazard ratio of 4.1 [95% confidence interval (CI): 1.3-12.6, p=0.014] ( Table 3) . SNS abnormality had an incremental and additive prognostic power in combination with high CRP with an adjusted hazard ratio of 4.1 (95% CI: 1.5-10.9, p=0.006).
Discussion
SNS abnormality is predictive of vascular events in patients with idiopathic paroxysmal AF. A combination of SNS Fig. 1 Receiver-operating characteristic curve comparing sensitivity and specificity of the H/M ratio for predicting vascular events. Optimal thresholds for the prediction of the H/M ratio =2.67 (sensitivity of 73.7% and specificity of 82%) abnormality and high CRP had incremental and additive prognostic power of the vascular events.
Role of SNS abnormality in the aetiology of idiopathic paroxysmal AF SNS abnormality has been suggested as an important mechanism involved in cardiovascular events, heart failure and stroke [11, 18] . Impairment of presynaptic catecholamine reuptake, which can be assessed by the norepinephrine analogue 123 I-MIBG, has been reported to be a predictor of morbidity or mortality in patients with structural heart diseases [19, 20] as well as atrial [21] and ventricular rhythm disorders [14, 22] . For patients with AF, the electrical and structural remodelling of the atria is the most frequent biological change, which causes haemodynamic change of the heart. When compensatory support is needed to meet the demands of organ perfusion due to haemodynamic overload, the cardiac adrenergic system becomes maladaptive and can cause the change that increases susceptibility to AF [23] . Mabuchi et al. [21] first reported using 123 I-MIBG scintigraphy and that SNS abnormality was associated with AF in 13 patients with chronic AF. They suggested that SNS abnormality reflected left ventricular dysfunction in patients with AF.
On the other hand, the autonomic nervous system itself plays an important role in both initiation and/or the maintenance of AF independent of left ventricular function [24] . This neuronal system abnormality has been indirectly measured using heart rate variability which may represent a CI confidence interval, H/M ratio heart to mediastinum ratio, CRP serum concentration of C-reactive protein, LAD left atrial dimension, NS nonsignificant global cardiac neuronal function and does not mean the regional abnormality on a part of the atrium in AF. Using left ventricular 123 I-MIBG imaging, Kasama et al. [25] showed that SNS abnormality correlated to brain natriuretic peptide in patients with heart failure despite preserved LVEF, suggesting the significance of SNS abnormality for predicting mortality independent of cardiac function. Tamaki et al. [26] also demonstrated that left ventricular 123 I-MIBG imaging predicted sudden cardiac death independently of LVEF in patients with chronic heart failure. From these results and the fact that SNS abnormality obtained using left ventricular 123 I-MIBG imaging is correlated to heart rate variability [27] , left ventricular 123 I-MIBG imaging may be estimated as global cardiac SNS integrity on the whole heart, but not as the regional change. As a result, it may have been possible to evaluate the vascular events in patients with AF and to find the close relationship between SNS abnormality and vascular events independent of LAD enlargement or subsequent left ventricular dysfunction as the factors caused by structural remodelling.
Osranek et al. [15] reported the significance of LAD enlargement as a predictor of vascular events for long-term follow-up in 46 patients with lone permanent AF. However, LAD did not predict the vascular events in our patients with idiopathic paroxysmal AF because the remarkable structural remodelling had not yet been caused. Our results indicate that electrical remodelling rather than structural remodelling leads to SNS abnormality in patients with paroxysmal AF, and the oxidative stress which results from SNS abnormality and/or inflammation may be associated with the vascular events in patients with paroxysmal AF [28] [29] [30] . An evaluation of SNS abnormality using 123 I-MIBG scintigraphy may be an option for screening high-risk patients with paroxysmal AF before the development of LAD enlargement and subsequent cardiac dysfunction which would be caused by permanent AF. Further, the prevention of SNS abnormality may be a key for the prognosis of patients with idiopathic paroxysmal AF.
Role of SNS abnormality with inflammation in the aetiology of idiopathic paroxysmal AF Thrombosis appears to be intimately related to inflammation [31] , and inflammation is well recognized as a predictor of adverse outcomes in many studies of healthy subjects, patients with vascular disease [32, 33] and those with AF [12] . Further, development, recurrence and persistence of AF are associated with enhanced myocardial tissue inflammation [31] . The high inflammatory state may drive the prothrombotic state in AF, which may contribute to the increased risk of thrombogenesis, and subsequently thromboembolism. Of the inflammatory biomarkers, particularly CRP is suitable for longer term prediction of mortality because CRP not only has prothrombotic but also antithrombotic effects [34] . Cardiac neuronal system abnormality is also a long-term predictor of mortality [35] . Thus, SNS abnormality and high CRP have been identified as risk factors for morbidity and mortality in a broad spectrum of conditions ranging from the healthy and general population to patients with coronary artery disease, heart failure and AF [11, 18, 32, 33] . Further, recent studies demonstrate the interrelation of those. Sajadieh et al. [36] reported using heart rate variability and that SNS abnormality was independently related to inflammation in patients without structural heart disease. Diakakis et al. [37] also reported the close relationship of neuronal system and inflammation using 123 I-MIBG scintigraphy in patients with heart failure and diabetes mellitus. Mechanisms responsible for potential interaction between SNS abnormality and inflammation remain unclear in patients with paroxysmal AF. Bone marrow [38] and the lymphoreticular system [39] are innervated by autonomic nerves, and on the contrary, those influence SNS activity. SNS activity may promote coagulation (via upregulation of platelet activation and factor VIII and downregulation of the fibrinolytic system) [40, 41] and inflammation (via upregulation of Thelper cytokines) [42, 43] . Thus, SNS abnormality, high CRP and these interactions may be epiphenomena of atherosclerosis. The cardiovascular basis for raised inflammation relates to oxidative stress [44] that perpetuates structural [45] and electrical [46] remodelling in AF. This oxidative stress caused by atrial remodelling leads to high CRP and SNS abnormality, and one accelerates the other. Thus, these can induce, and be further stimulated by, thrombolytic events such as acute myocardial infarction and ischaemic strokes.
Study limitation
Our results are based upon a single centre experience with patients referred for history of AF which may limit the H/M ratio heart to mediastinum ratio, CRP serum concentration of C-reactive protein more general applicability of the findings. We investigated SNS abnormality as a predictor of morbidity in a limited number of patients. However, the 69 patients reported are well characterized, have been followed for a long period and may therefore be accepted as a relatively large cohort given the rarity of the disease similarly to a previous study with a small sample [5] . More work in a study with a greater sample size may be needed to investigate the mechanism of the close relationship between SNS abnormality with inflammation and mortality. The H/M ratio on the delayed 123 I-MIBG images was used as a value of SNS integrity similar to our previous studies [13, 14] because this value is considered to contain combined information regarding both uptake function at the cardiac sympathetic nerve ending and distribution (accumulation of early 123 I-MIBG images) and the degree of sympatheticotonia (washout ratio of 123 I-MIBG) [47] . However, the washout ratio of 123 I-MIBG images is also a prognostic marker of mortality [26] although the H/M ratio on early images or washout ratio were not evaluated in the present study. We used medium-energy collimators in the present study because medium-energy collimators provide higher quantitative accuracy compared to low-energy collimators, which are commonly applied in cardiac 123 I-MIBG imaging [48, 49] . The influences on the planar H/M ratios by scatter or septal penetration were less pronounced for medium-energy, and as a result, the H/M ratio value obtained in our study patients was higher compared to others [19, 20, 22] . In our laboratory, our study patients with paroxysmal AF were significantly lower in H/M ratio than normal values (versus 3.3±0.5, p<0.0001). It is well known that there is variability in MIBG distribution, and there are significant variations regarding H/M values from nuclear medicine centre to another in both normal subjects and patients with heart disease. Similar to many previous prognostic studies, the predictive markers were evaluated using one data item which was picked up on the stable condition after the occurrence of paroxysmal AF and before development of subsequent serious events in patients with no structural heart disease and preserved cardiac function because these markers are likely to be influenced by the acute conditions other than the occurrence of paroxysmal AF such as invasive interventions, development of structural heart disease or other events which are not related to vascular disease. However, repeated collections of data may estimate that sympathetic dysfunction or inflammation go from bad to worse during long-term follow-up.
